Publications by authors named "Mary Morris"

Article Synopsis
  • - The study focused on understanding the genetic causes of autism spectrum disorder (ASD) by sequencing the DNA of 754 individuals from 195 families, identifying a total of 38,834 new genetic variants.
  • - Researchers discovered 92 potentially harmful genetic variations in 73 known genes among 68 individuals with ASD, along with 158 likely damaging variants in 120 other candidate genes.
  • - The findings enhance our knowledge of ASD genetics, revealing patterns linked to brain development and cellular signaling, which could aid in diagnosing and developing treatments for the disorder.
View Article and Find Full Text PDF
Article Synopsis
  • Research on the effectiveness of COVID-19 convalescent plasma (CCP) in treating immunocompromised patients is still inconclusive.
  • In a study, hamsters infected with SARS-CoV-2 were treated with CCP from vaccinated recovered patients (Vaxplas), which temporarily worsened disease severity and lung issues due to immune responses.
  • Despite the temporary enhancement of the disease, Vaxplas significantly lowered virus levels in the lungs and improved overall outcomes in the infected hamsters.
View Article and Find Full Text PDF
Article Synopsis
  • The effectiveness of COVID-19 convalescent plasma (CCP) for treating immunocompromised patients, particularly those who can't produce antibodies or have issues with existing antivirals, is still uncertain.
  • A study on hamsters infected with SARS-CoV-2 showed that plasma from vaccinated recovered COVID patients (termed Vaxplas) significantly reduced viral replication and improved health outcomes.
  • However, Vaxplas also temporarily worsened disease severity and lung damage in the animals, likely due to immune responses that increased inflammation and attracted more aggressive immune cells to the lungs.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness of a broad-spectrum vaccine, DCFHP-alum, against various COVID-19 variants, questioning if variant-specific vaccines are the best option.
  • DCFHP-alum successfully generates neutralizing antibodies against all known COVID-19 variants and even SARS-CoV-1 in non-human primates.
  • The research concludes that using a stable, ancestral virus structure (Wuhan-1) without specific mutations leads to better immune responses and highlights potential drawbacks of developing vaccines tailored to specific viral variants.
View Article and Find Full Text PDF

Unlabelled: Prostate cancer progression to the lethal metastatic castration-resistant phenotype (mCRPC) is driven by αv integrins and is associated with Golgi disorganization and activation of the ATF6 branch of unfolded protein response (UPR). Overexpression of integrins requires N-acetylglucosaminyltransferase-V (MGAT5)-mediated glycosylation and subsequent cluster formation with Galectin-3 (Gal-3). However, the mechanism underlying this altered glycosylation is missing.

View Article and Find Full Text PDF

While the rapid development of COVID-19 vaccines has been a scientific triumph, the need remains for a globally available vaccine that provides longer-lasting immunity against present and future SARS-CoV-2 variants of concern (VOCs). Here, we describe DCFHP, a ferritin-based, protein-nanoparticle vaccine candidate that, when formulated with aluminum hydroxide as the sole adjuvant (DCFHP-alum), elicits potent and durable neutralizing antisera in non-human primates against known VOCs, including Omicron BQ.1, as well as against SARS-CoV-1.

View Article and Find Full Text PDF

Objective: To report a case of ovarian torsion during ovarian stimulation prior to trigger followed by laparoscopic detorsion, trigger, and subsequent successful oocyte retrieval, as well as to review outcomes from the cycle.

Case Presentation: A 32-year-old woman with a history of recurrent ovarian torsion presented with ovarian torsion during ovarian stimulation for in vitro fertilization prior to trigger injection. She underwent laparoscopic ovarian detorsion followed by trigger and oocyte retrieval.

View Article and Find Full Text PDF

While the rapid development of COVID-19 vaccines has been a scientific triumph, the need remains for a globally available vaccine that provides longer-lasting immunity against present and future SARS-CoV-2 variants of concern (VOCs). Here, we describe DCFHP, a ferritin-based, protein-nanoparticle vaccine candidate that, when formulated with aluminum hydroxide as the sole adjuvant (DCFHP-alum), elicits potent and durable neutralizing antisera in non-human primates against known VOCs, including Omicron BQ.1, as well as against SARS-CoV-1.

View Article and Find Full Text PDF

Nonhuman primates living in proximity to humans increase risks for sylvatic arbovirus transmission. We collected serum samples from nonhuman primates in Hlawga National Park near Yangon, Myanmar, and detected antibodies against chikungunya (33%) and Japanese encephalitis (4%) viruses. Buffer zones between primate and human communities might reduce cross-species arbovirus transmission.

View Article and Find Full Text PDF

Background And Objectives: Internal neurofibromas, including plexiform neurofibromas (PNF), can cause significant morbidity in patients with neurofibromatosis type 1 (NF1). PNF growth is most pronounced in children and young adults, with more rapid growth thought to occur in a subset of PNF termed distinct nodular lesions (DNL). Growth behavior of internal neurofibromas and DNL in older adults is not well documented; yet knowledge thereof is important for patient risk stratification and clinical trial design.

View Article and Find Full Text PDF

The estrous cycle is regulated by rhythmic endocrine interactions of the nervous and reproductive systems, which coordinate the hormonal and ovulatory functions of the ovary. Folliculogenesis and follicle progression require the orchestrated response of a variety of cell types to allow the maturation of the follicle and its sequela, ovulation, corpus luteum formation, and ovulatory wound repair. Little is known about the cell state dynamics of the ovary during the estrous cycle and the paracrine factors that help coordinate this process.

View Article and Find Full Text PDF
Article Synopsis
  • * It involved 86 participants, comparing unvaccinated (24) and vaccinated (62) individuals who were infected with either Delta or BA.1 variants.
  • * Findings showed unvaccinated individuals had weak antibody responses, while vaccinated participants developed moderate to strong antibodies against BA.2, with BA.2 responses generally higher than BA.1.
View Article and Find Full Text PDF

Omicron and its subvariants have rendered most authorized monoclonal antibody-based treatments for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ineffective, highlighting the need for biologics capable of overcoming SARS-CoV-2 evolution. These mostly ineffective antibodies target variable epitopes. Here we describe broad-spectrum SARS-CoV-2 inhibitors developed by tethering the SARS-CoV-2 receptor, angiotensin-converting enzyme 2 (ACE2), to known non-neutralizing antibodies that target highly conserved epitopes in the viral spike protein.

View Article and Find Full Text PDF
Article Synopsis
  • A new serological assay called the Split-Oligonucleotide Neighboring Inhibition Assay (SONIA) is developed to effectively detect neutralizing antibodies against SARS-CoV-2, which is crucial for monitoring herd immunity and vaccine effectiveness.
  • SONIA utilizes real-time qPCR to assess how well these antibodies can prevent viral spike proteins from binding to human receptors, achieving high sensitivity (91-97%) and perfect specificity (100%) when compared to traditional methods.
  • The assay is performed with finger-prick dried blood spots, making it easy to collect, and offers insights into various factors such as age, health conditions, immunity changes, vaccination differences, and the rise of new virus variants.
View Article and Find Full Text PDF

SARS-CoV-2 Delta and Omicron are globally relevant variants of concern. Although individuals infected with Delta are at risk of developing severe lung disease, infection with Omicron often causes milder symptoms, especially in vaccinated individuals. The question arises of whether widespread Omicron infections could lead to future cross-variant protection, accelerating the end of the pandemic.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers studied neutralizing immunity against Delta and Omicron variants of SARS-CoV-2 by analyzing 259 samples from 128 vaccinated individuals using virus-like particle (VLP) and live virus assays.
  • After Delta breakthrough infections, individuals showed a much higher increase in antibody levels against the wild type (WT) strain compared to Omicron infections, which showed minimal increase.
  • The findings indicate that Omicron breakthrough infections are less effective in boosting immunity than Delta infections, likely due to more mild or asymptomatic cases, which could lead to lower protection against future infections or variants.
View Article and Find Full Text PDF

BackgroundThe Delta and Omicron variants of SARS-CoV-2 are currently responsible for breakthrough infections due to waning immunity. We report phase I/II trial results of UB-612, a multitope subunit vaccine containing S1-RBD-sFc protein and rationally designed promiscuous peptides representing sarbecovirus conserved helper T cell and cytotoxic T lymphocyte epitopes on the nucleocapsid (N), membrane (M), and spike (S2) proteins.MethodWe conducted a phase I primary 2-dose (28 days apart) trial of 10, 30, or 100 μg UB-612 in 60 healthy young adults 20 to 55 years old, and 50 of them were boosted with 100 μg of UB-612 approximately 7 to 9 months after the second dose.

View Article and Find Full Text PDF

As novel SARS-CoV-2 variants continue to emerge, it is critical that their potential to cause severe disease and evade vaccine-induced immunity is rapidly assessed in humans and studied in animal models. In early January 2021, a novel SARS-CoV-2 variant designated B.1.

View Article and Find Full Text PDF

Associations between vaccine breakthrough cases and infection by different SARS coronavirus 2 (SARS-CoV-2) variants have remained largely unexplored. Here we analysed SARS-CoV-2 whole-genome sequences and viral loads from 1,373 persons with COVID-19 from the San Francisco Bay Area from 1 February to 30 June 2021, of which 125 (9.1%) were vaccine breakthrough infections.

View Article and Find Full Text PDF

Background: The development of persistent endoplasmic reticulum (ER) stress is one of the cornerstones of prostate carcinogenesis; however, the mechanism is missing. Also, alcohol is a physiological ER stress inducer, and the link between alcoholism and progression of prostate cancer (PCa) is well documented but not well characterized. According to the canonical model, the mediator of ER stress, ATF6, is cleaved sequentially in the Golgi by S1P and S2P proteases; thereafter, the genes responsible for unfolded protein response (UPR) undergo transactivation.

View Article and Find Full Text PDF

Previous work from our laboratories has identified multiple defects in endocytosis, protein trafficking, and secretion, along with altered Golgi function after alcohol administration. Manifestation of alcohol-associated liver disease (ALD) is associated with an aberrant function of several hepatic proteins, including asialoglycoprotein receptor (ASGP-R), their atypical distribution at the plasma membrane (PM), and secretion of their abnormally glycosylated forms into the bloodstream, but trafficking mechanism is unknown. Here we report that a small GTPase, Rab3D, known to be involved in exocytosis, secretion, and vesicle trafficking, shows ethanol (EtOH)-impaired function, which plays an important role in Golgi disorganization.

View Article and Find Full Text PDF

The Abbott BinaxNOW rapid antigen test is cheaper and faster than real-time reverse transcription PCR (rRT-PCR) for detecting severe acute respiratory syndrome coronavirus 2. We compared BinaxNOW with rRT-PCR in 769 paired specimens from 342 persons during a coronavirus disease outbreak among horse racetrack workers in California, USA. We found positive percent agreement was 43.

View Article and Find Full Text PDF